ALAIN TORRES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TAMPA, FL NPI 1225655293
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FL Eli Lilly and Company All categories
General Payments — all program years on this page
$624.73
- Category: General Payments
- Program years: PY2021–2023
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $558.68 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $430.02 | 1 |
| Food and Beverage | $128.66 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $430.02 | 1 |
| GlaxoSmithKline, LLC. | $47.36 | 2 |
| Exact Sciences Corporation | $40.05 | 2 |
| Lucid Diagnostics Inc. | $26.71 | 2 |
| Acerta Pharma LLC | $14.54 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1004352017 | GlaxoSmithKline, LLC. | $32.29 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1004353619 | GlaxoSmithKline, LLC. | $15.07 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1011383661 | AstraZeneca Pharmaceuticals LP | $14.54 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1026835597 | Exact Sciences Corporation | $21.06 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1026835631 | Exact Sciences Corporation | $18.99 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1032739947 | Eli Lilly and Company | $430.02 | 03/06/2023 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1057663941 | Lucid Diagnostics Inc. | $12.91 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1057663945 | Lucid Diagnostics Inc. | $13.80 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.